Market Place
Sourcing Support
Dr. Reddy`s Announces Launch of Saxagliptin and Metformin Hydrochloride Tablets
10 Aug 2023 //
BUSINESSWIRE
Glenmark gets USFDA nod to market generic diabetes drug
01 Aug 2023 //
ECONOMIC TIMES
Glenmark gets USFDA nod to market generic diabetes drug
01 Jul 2023 //
ECONOMIC TIMES
Glenmark gets USFDA nod for generic diabetes drug
16 Feb 2023 //
ECONOMIC TIMES
Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets
28 Apr 2020 //
ECONOMICTIMES
AstraZeneca receives marketing approval for dapagliflozin 10mg + saxagliptin 5mg
26 Sep 2019 //
PHARMABIZ
EMA committee recommends marketing approval for AstraZeneca`s Qtrilmet
25 Sep 2019 //
PHARMABIZ
Xospata leads latest CHMP recommendations
21 Sep 2019 //
PHARMATIMES
EMA`s CHMP Recommends Three New Medicines
20 Sep 2019 //
RAPS
Teva Pharms USA’s Generic Saxagliptin Receives Tentative Approval in the US
14 Jul 2018 //
FDA
AZ hopes diabetes drug could be as effective as gastric band
11 Jul 2018 //
PHARMA PHORUM
Busy AZ posts Q4 beats, with execs promising skid`s end is near
02 Feb 2018 //
FIERCE PHARMA
AZ books 3 percent sales drop for Q3
09 Nov 2017 //
PHARMA TIMES
Glenmark Pharm’s Generic Saxagliptin Receives Tentative Approval In US
14 Jun 2017 //
FDA
Glenmark Pharm’s Generic Saxagliptin Receives Approval In Us
13 Jun 2017 //
FDA
BMS, AZ in legal hot seat over Onglyza heart failure warning
09 May 2017 //
FIERCE PHARMA
FDA rejects CV outcomes claim for Merck diabetes drugs
11 Apr 2017 //
PHARMA TIMES
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
14 Mar 2017 //
FIERCE PHARMA
AZ gets US approval for diabetes combo Qtern
01 Mar 2017 //
PMLIVE
AZ bounces back with diabetes combo win, but can it keep up with Lilly and BI?
28 Feb 2017 //
FIERCE PHARMA
UK sees first global launch of AZ’ diabetes combo Qtern
26 Jan 2017 //
PHARMATIMES
European Commission approves AstraZeneca`s Qtern for type 2 diabetes treatment
21 Jul 2016 //
PHARMABIZ
AZ`s Lynparza misses the mark in gastric cancer trial
19 May 2016 //
FIERCE PHARMA
Two Indian generics makers end battle to copy drugs amid patent debate
13 Apr 2016 //
REUTERS
India’s Patent Office Rejects Lee Pharma’s Compulsory License Application
20 Jan 2016 //
TWOFOUR INSIGHT
India rejects compulsory license app of Lee Pharma against AZ’s Saxagliptin
20 Jan 2016 //
ECONOMIC TIMES
British drug maker AstraZeneca may launch innovative drugs in India
14 Jan 2016 //
ET HEALTHWORLD
AstraZeneca seeks hearing patent controller regarding Lee`s CL application
16 Dec 2015 //
BUSINESS STANDARD
More formulary exclusion are on their way as smaller PBMs get in the action
02 Dec 2015 //
FIERCE PHARMA
Lee Pharma to appear for fresh hearing on compulsory licence
18 Nov 2015 //
THE HINDU
FDA warning on J&J`s Invokana adds more complexities to diabetes drug battles
12 Sep 2015 //
FIERCE PHARMA
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
29 Aug 2015 //
REUTERS
India rejects Lee Pharma’s compulsory licence plea
18 Aug 2015 //
THE ECONOMIC TIMES
FDA`s SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
19 May 2015 //
FIERCE PHARMA
Merck Gains Edge on Rivals With Results About its Diabetes Drug
29 Apr 2015 //
PHARMALOT
Onglyza`s label should flag heart failure risks, FDA panel says
14 Apr 2015 //
FIERCE PHARMA
Astrazeneca Bullish on Diabetes Franchise Fortunes
13 Mar 2015 //
PMLIVE
